Biodexa Pharmaceuticals Analyst Price Targets - Benzinga

Biodexa Pharmaceuticals PLC

BDRXNASDAQ

Trade with Public

Trade with Public

$3.43

-0.47-12.05%

Últ. Act.: Oct 30, 7:28 PM

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Comparar Informe de acciones

© 2026 Benzinga | All Rights Reserved

Biodexa Pharmaceuticals Analyst Price Targets - Benzinga

Biodexa Pharmaceuticals Analyst Price Targets

Wall Street analyst price targets and consensus rating for Biodexa Pharmaceuticals (BDRX).

Price Target Range — 1 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$80000Upside to Avg. PT+2539582.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Feb 8, 2024	Ladenburg Thalmann	Aydin Huseynov	Initiate	Buy	$80000

Analyst Ratings News

PRO
Watching Biodexa Pharmaceuticals; Zacks Small-Cap Research Gives Stock $9 Price Valuation

Benzinga Newsdesk

PRO
Watching Biodexa Pharmaceuticals; Zacks Small-Cap Research Gives Stock $10 Price Valuation

Benzinga Newsdesk

PRO
Ladenburg Thalmann Initiates Coverage On Biodexa Pharmaceuticals with Buy Rating, Announces Price Target of $8

Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on Biodexa Pharmaceuticals (NASDAQ:BDRX) with a Buy rating and announces Price Target of $8.

Benzinga Newsdesk